Form 8-K - Current report:
SEC Accession No. 0001104659-25-053861
Filing Date
2025-05-29
Accepted
2025-05-29 07:00:30
Documents
12
Period of Report
2025-05-28
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2516431d1_8k.htm   iXBRL 8-K 43096
  Complete submission text file 0001104659-25-053861.txt   212821

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ckpt-20250528.xsd EX-101.SCH 3026
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ckpt-20250528_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ckpt-20250528_pre.xml EX-101.PRE 22366
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2516431d1_8k_htm.xml XML 3685
Mailing Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453
Business Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453 781-652-4500
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

EIN.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38128 | Film No.: 25997651
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)